XNCR FY 2025 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena

XNCRXencor, Inc.

$890M

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$126M+13.7% YoY

Gross Profit

$115M91.6% margin

Operating Income

-$178M-141.4% margin

Net Income

-$92M-73.2% margin

EPS (Diluted)

$-1.24

Cash Flow

Operating Cash Flow

-$135M

Free Cash Flow

-$138M

Stock-Based Comp.

$43M

Balance Sheet

Total Assets

$875M

Total Liabilities

$240M

Stockholders' Equity

$636M

Cash & Equivalents

$54M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$126M	$110M	+13.7%
Gross Profit	$115M	$110M	+4.1%
Operating Income	-$178M	-$178M	+0.5%
Net Income	-$92M	-$233M	+60.5%